4.5 Article

Functional Genetic Variants in the 3′-Untranslated Region of Sulfotransferase Isoform 1A1 (SULT1A1) and Their Effect on Enzymatic Activity

Journal

TOXICOLOGICAL SCIENCES
Volume 118, Issue 2, Pages 391-403

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/toxsci/kfq296

Keywords

SULT1A1; genotype; phenotype; pharmacogenetics

Categories

Funding

  1. National Cancer Institute at the National Institutes of Health [R01CA128897]
  2. National Center for Research Resources [1UL1RR029884]
  3. Susan G. Komen for the Cure [BCTR0707584]

Ask authors/readers for more resources

Sulfotransferase isoform 1A1 (SULT1A1) is the most highly expressed hepatic sulfotransferase and is involved in the biotransformation of a wide variety of endo- and xenobiotics. A common single nucleotide polymorphism (SNP) in the coding region of SULT1A1, several proximal promoter SNPs, and copy number variation (CNV) are associated with altered enzymatic activity, but these variants do not fully account for the observed variation of SULT1A1 activity in human populations. In order to identify additional SNPs modulating SULT1A1 activity, we examined the 3'-untranslated region (UTR) of SULT1A1 in 97 liver samples. Direct sequencing revealed that two SNPs in the 3'-UTR (902A > G [rs6839] and 973C > T [rs1042157]) and one SNP in the 3'-flanking region (1307G > A [rs4788068]) were common. These SNPs are in absolute linkage disequilibrium with each other and in tight linkage with SULT1A1*1/2 (linkage coefficient D' 0.83) and are significantly associated with SULT1A1 messenger RNA (p = 0.001, 0.029, 0.021) and enzymatic activity (p = 0.022, 0.012, 0.027). We then examined the collective effects of 3'-UTR SNPs, SULT1A1*1/2, and CNV on SULT1A1 activity in 498 Caucasian and 127 African-American subjects by haplotype analysis. This analysis revealed that SULT1A1*1/2 does not contribute to the variation in SULT1A1 enzymatic activity when the 3'-UTR SNPs are included in the statistical model. Two major haplotypes (ACG and GTA) were significantly correlated with SULT1A1 activity, and when stratified by copy number, the SULT1A1 3'-UTR SNPs remain significantly associated with SULT1A1 enzymatic activity in Caucasians, but not in African-Americans. Subsequent functional characterization revealed that a microRNA, miR-631, regulates SULT1A1 expression in a genotype-specific manner.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Toxicology

The role of hepatic cytochrome P450s in the cytotoxicity of sertraline

Si Chen, Qiangen Wu, Xilin Li, Dongying Li, Michelle Fan, Zhen Ren, Matthew Bryant, Nan Mei, Baitang Ning, Lei Guo

ARCHIVES OF TOXICOLOGY (2020)

Article Toxicology

Long noncoding RNA LINC00844-mediated molecular network regulates expression of drug metabolizing enzymes and nuclear receptors in human liver cells

Dongying Li, Leihong Wu, Bridgett Knox, Si Chen, William H. Tolleson, Fang Liu, Dianke Yu, Lei Guo, Weida Tong, Baitang Ning

ARCHIVES OF TOXICOLOGY (2020)

Article Pharmacology & Pharmacy

MicroRNA hsa-miR-1301-3p Regulates Human ADH6, ALDH5A1 and ALDH8A1 in the Ethanol-Acetaldehyde-Acetate Metabolic Pathway

Xubing Wang, Yanjie Zhao, Jiao Luo, Lin Xu, Xinmei Li, Yuan Jin, Chuanhai Li, Meiyao Feng, Ying Wang, Jing Chen, Yufei Hou, Qianwen Zhao, Jinquan Zhao, Baitang Ning, Yuxin Zheng, Dianke Yu

MOLECULAR PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

A comprehensive rat transcriptome built from large scale RNA-seq-based annotation

Xiangjun Ji, Peng Li, James C. Fuscoe, Geng Chen, Wenzhong Xiao, Leming Shi, Baitang Ning, Zhichao Liu, Huixiao Hong, Jun Wu, Jinghua Liu, Lei Guo, David P. Kreil, Pawel P. Labaj, Liping Zhong, Wenjun Bao, Yong Huang, Jian He, Yongxiang Zhao, Weida Tong, Tieliu Shi

NUCLEIC ACIDS RESEARCH (2020)

Article Toxicology

Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing

Dongying Li, Bridgett Knox, Binsheng Gong, Si Chen, Lei Guo, Zhichao Liu, Weida Tong, Baitang Ning

Summary: The study focused on investigating miRNA biomarkers for KCZ-induced liver injury by integrating in vivo, in vitro, and bioinformatics analyses. Significant dysregulation of miR-34a-5p, miR-331-3p, and miR-15b-3p was associated with cytoplasmic vacuolization in rat livers with KCZ-induced injury. These miRNAs, along with miR-676, showed evolutionary conservation and could potentially serve as translational biomarkers for early detection of liver injury.

TOXICOLOGICAL SCIENCES (2021)

Review Pharmacology & Pharmacy

Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics

Li Zeng, Dongying Li, Weida Tong, Tieliu Shi, Baitang Ning

Summary: The study proposes a method to monitor and predict the impact of viral mutations on drug safety and efficacy, emphasizing the importance of the three main viral proteins and suggesting the establishment of an interactive database.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Chemistry, Medicinal

Impact of Sequencing Depth and Library Preparation on Toxicological Interpretation of RNA-Seq Data in a Three-Sample Scenario

Dongying Li, Binsheng Gong, Joshua Xu, Baitang Ning, Weida Tong

Summary: This study investigated the impact of sequencing depth and library preparation on toxicological interpretation in RNA-seq using three samples. Results showed that a minimum of 20 million reads was sufficient to reveal key toxicity pathways, and identification of differentially expressed genes was positively associated with sequencing depth. Overall, RNA-seq had higher statistical power and overlap ratio in toxicological insights compared to TempO-seq and microarray.

CHEMICAL RESEARCH IN TOXICOLOGY (2021)

Review Pharmacology & Pharmacy

Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges

Kiara Fairman, Miao Li, Baitang Ning, Annie Lumen

Summary: PBPK modeling is a powerful tool with potential applications in the development of RNAi therapeutics, a class of drugs with unique pharmacokinetic properties. While there is active research in this area, there are still challenges to fully evaluating the utility of PBPK models for RNAi therapeutics. The current computational modeling approaches can support efficient development and approval of RNAi therapeutics, but further exploration and standardization are needed to optimize their use.

BIOCHEMICAL PHARMACOLOGY (2021)

Editorial Material Pharmacology & Pharmacy

RNA therapeutics: From biochemical pharmacology to technology development and clinical applications Preface

Baitang Ning, Ai-Ming Yu

BIOCHEMICAL PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Towards population-specific pharmacogenomics in the era of next-generation sequencing

Xiangjun Ji, Baitang Ning, Jinghua Liu, Ruth Roberts, Larry Lesko, Weida Tong, Zhichao Liu, Tieliu Shi

Summary: Pharmacogenomics plays essential roles in optimizing drug responses and avoiding adverse events. Population-specific therapeutic interventions and genotyping can improve clinical outcomes, highlighting the importance of precision medicine strategies. Challenges and regulatory efforts still exist in advancing this field further.

DRUG DISCOVERY TODAY (2021)

Article Biotechnology & Applied Microbiology

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing

Wenming Xiao, Luyao Ren, Zhong Chen, Li Tai Fang, Yongmei Zhao, Justin Lack, Meijian Guan, Bin Zhu, Erich Jaeger, Liz Kerrigan, Thomas M. Blomquist, Tiffany Hung, Marc Sultan, Kenneth Idler, Charles Lu, Andreas Scherer, Rebecca Kusko, Malcolm Moos, Chunlin Xiao, Stephen T. Sherry, Ogan D. Abaan, Wanqiu Chen, Xin Chen, Jessica Nordlund, Ulrika Liljedahl, Roberta Maestro, Maurizio Polano, Jiri Drabek, Petr Vojta, Sulev Koks, Ene Reimann, Bindu Swapna Madala, Timothy Mercer, Chris Miller, Howard Jacob, Tiffany Truong, Ali Moshrefi, Aparna Natarajan, Ana Granat, Gary P. Schroth, Rasika Kalamegham, Eric Peters, Virginie Petitjean, Ashley Walton, Tsai-Wei Shen, Keyur Talsania, Cristobal Juan Vera, Kurt Langenbach, Maryellen de Mars, Jennifer A. Hipp, James C. Willey, Jing Wang, Jyoti Shetty, Yuliya Kriga, Arati Raziuddin, Bao Tran, Yuanting Zheng, Ying Yu, Margaret Cam, Parthav Jailwala, Cu Nguyen, Daoud Meerzaman, Qingrong Chen, Chunhua Yan, Ben Ernest, Urvashi Mehra, Roderick Jensen, Wendell Jones, Jian-Liang Li, Brian N. Papas, Mehdi Pirooznia, Yun-Ching Chen, Fayaz Seifuddin, Zhipan Li, Xuelu Liu, Wolfgang Resch, Jingya Wang, Leihong Wu, Gokhan Yavas, Corey Miles, Baitang Ning, Weida Tong, Christopher E. Mason, Eric Donaldson, Samir Lababidi, Louis M. Staudt, Zivana Tezak, Huixiao Hong, Charles Wang, Leming Shi

Summary: This study systematically investigates factors affecting detection reproducibility and accuracy of somatic mutations in paired tumor-normal cell lines at six different centers. It evaluates the reproducibility of whole-genome sequencing (WGS) and whole-exome sequencing (WES) for different sample types, input amounts, tumor purity, and library construction protocols with nine bioinformatics pipelines. The study found that read coverage and callers affected both WGS and WES reproducibility, with WES performance also affected by insert fragment size, genomic copy content, and the global imbalance score.

NATURE BIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing

Li Tai Fang, Bin Zhu, Yongmei Zhao, Wanqiu Chen, Zhaowei Yang, Liz Kerrigan, Kurt Langenbach, Maryellen de Mars, Charles Lu, Kenneth Idler, Howard Jacob, Yuanting Zheng, Luyao Ren, Ying Yu, Erich Jaeger, Gary P. Schroth, Ogan D. Abaan, Keyur Talsania, Justin Lack, Tsai-Wei Shen, Zhong Chen, Seta Stanbouly, Bao Tran, Jyoti Shetty, Yuliya Kriga, Daoud Meerzaman, Cu Nguyen, Virginie Petitjean, Marc Sultan, Margaret Cam, Monika Mehta, Tiffany Hung, Eric Peters, Rasika Kalamegham, Sayed Mohammad Ebrahim Sahraeian, Marghoob Mohiyuddin, Yunfei Guo, Lijing Yao, Lei Song, Hugo Y. K. Lam, Jiri Drabek, Petr Vojta, Roberta Maestro, Daniela Gasparotto, Sulev Koks, Ene Reimann, Andreas Scherer, Jessica Nordlund, Ulrika Liljedahl, Roderick Jensen, Mehdi Pirooznia, Zhipan Li, Chunlin Xiao, Stephen T. Sherry, Rebecca Kusko, Malcolm Moos, Eric Donaldson, Zivana Tezak, Baitang Ning, Weida Tong, Jing Li, Penelope Duerken-Hughes, Claudia Catalanotti, Shamoni Maheshwari, Joe Shuga, Winnie S. Liang, Jonathan Keats, Jonathan Adkins, Erica Tassone, Victoria Zismann, Timothy McDaniel, Jeffrey Trent, Jonathan Foox, Daniel Butler, Christopher E. Mason, Huixiao Hong, Leming Shi, Charles Wang, Wenming Xiao

Summary: This study presents reference call sets obtained from paired tumor-normal genomic DNA samples from a breast cancer cell line and a lymphoblastoid cell line. These samples were partially validated for somatic mutations and germline variants through whole-exome sequencing and targeted sequencing. The use of these samples can help calibrate clinical sequencing pipelines and provide a unique resource for benchmarking 'tumor-only' or 'matched tumor-normal' analyses.

NATURE BIOTECHNOLOGY (2021)

Article Genetics & Heredity

X-CNV: genome-wide prediction of the pathogenicity of copy number variations

Li Zhang, Jingru Shi, Jian Ouyang, Riquan Zhang, Yiran Tao, Dongsheng Yuan, Chengkai Lv, Ruiyuan Wang, Baitang Ning, Ruth Roberts, Weida Tong, Zhichao Liu, Tieliu Shi

Summary: The research team developed the X-CNV computational framework, integrating multiple informative features to predict the pathogenicity of CNVs, outperforming other tools. They also proposed an MVP score to quantitatively measure the pathogenic effect of CNVs, demonstrating high discriminative power.

GENOME MEDICINE (2021)

Article Biotechnology & Applied Microbiology

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions

Binsheng Gong, Dan Li, Rebecca Kusko, Natalia Novoradovskaya, Yifan Zhang, Shangzi Wang, Carlos Pabon-Pena, Zhihong Zhang, Kevin Lai, Wanshi Cai, Jennifer S. LoCoco, Eric Lader, Todd A. Richmond, Vinay K. Mittal, Liang-Chun Liu, Donald J. Johann, James C. Willey, Pierre R. Bushel, Ying Yu, Chang Xu, Guangchun Chen, Daniel Burgess, Simon Cawley, Kristina Giorda, Nathan Haseley, Fujun Qiu, Katherine Wilkins, Hanane Arib, Claire Attwooll, Kevin Babson, Longlong Bao, Wenjun Bao, Anne Bergstrom Lucas, Hunter Best, Ambica Bhandari, Halil Bisgin, James Blackburn, Thomas M. Blomquist, Lisa Boardman, Blake Burgher, Daniel J. Butler, Chia-Jung Chang, Alka Chaubey, Tao Chen, Marco Chierici, Christopher R. Chin, Devin Close, Jeffrey Conroy, Jessica Cooley Coleman, Daniel J. Craig, Erin Crawford, Angela del Pozo, Ira W. Deveson, Daniel Duncan, Agda Karina Eterovic, Xiaohui Fan, Jonathan Foox, Cesare Furlanello, Abhisek Ghosal, Sean Glenn, Meijian Guan, Christine Haag, Xinyi Hang, Scott Happe, Brittany Hennigan, Jennifer Hipp, Huixiao Hong, Kyle Horvath, Jianhong Hu, Li-Yuan Hung, Mirna Jarosz, Jennifer Kerkhof, Benjamin Kipp, David Philip Kreil, Pablo Lapunzina, Peng Li, Quan-Zhen Li, Weihua Li, Zhiguang Li, Yu Liang, Shaoqing Liu, Zhichao Liu, Charles Ma, Narasimha Marella, Ruben Martin-Arenas, Dalila B. Megherbi, Qingchang Meng, Piotr A. Mieczkowski, Tom Morrison, Donna Muzny, Baitang Ning, Barbara L. Parsons, Cloud P. Paweletz, Mehdi Pirooznia, Wubin Qu, Amelia Raymond, Paul Rindler, Rebecca Ringler, Bekim Sadikovic, Andreas Scherer, Egbert Schulze, Robert Sebra, Rita Shaknovich, Qiang Shi, Tieliu Shi, Juan Carlos Silla-Castro, Melissa Smith, Mario Solis Lopez, Ping Song, Daniel Stetson, Maya Strahl, Alan Stuart, Julianna Supplee, Philippe Szankasi, Haowen Tan, Lin-ya Tang, Yonghui Tao, Shraddha Thakkar, Danielle Thierry-Mieg, Jean Thierry-Mieg, Venkat J. Thodima, David Thomas, Boris Tichy, Nikola Tom, Elena Vallespin Garcia, Suman Verma, Kimbley Walker, Charles Wang, Junwen Wang, Yexun Wang, Zhining Wen, Valtteri Wirta, Leihong Wu, Chunlin Xiao, Wenzhong Xiao, Shibei Xu, Mary Yang, Jianming Ying, Shun H. Yip, Guangliang Zhang, Sa Zhang, Meiru Zhao, Yuanting Zheng, Xiaoyan Zhou, Christopher E. Mason, Timothy Mercer, Weida Tong, Leming Shi, Wendell Jones, Joshua Xu

Summary: All panels exhibit high sensitivity for variants within the 5-20% VAF range in high-confidence coding regions, but sensitivity decreases when using VAF thresholds due to variability in VAF measurements. Enforcing a VAF threshold for reporting reduces false positive calls, and false positive rate is higher outside high-confidence coding regions, leading to lower reproducibility. Region restriction and VAF thresholds result in low technical variability in estimating promising biomarkers and tumor mutational burden.

GENOME BIOLOGY (2021)

Article Oncology

Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity

Si Chen, Qiangen Wu, Xilin Li, Dongying Li, Nan Mei, Baitang Ning, Montserrat Puig, Zhen Ren, William H. Tolleson, Lei Guo

Summary: This study confirmed the stability of CYP-overexpressing HepG2 cell lines in long-term cultures and demonstrated consistency in response to stimuli, providing valuable information for the broader use of these cells in pharmacologic and toxicologic research.

JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2021)

No Data Available